ERC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Endocrine-Related Cancer 5 (4) 311-314    DOI: 10.1677/erc.0.0050311
Copyright © 1998 by the Society for Endocrinology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liszka, G.
Right arrow Articles by Budai, B
Right arrow Search for Related Content
PubMed
Right arrow Articles by Liszka, G.
Right arrow Articles by Budai, B

Investigation of serum sex hormone levels in postmenopausal patients with multiple benign breast lesions detected by mammography

Gy Liszka 1, I Számel 2, I Pete 3, Á Petrányi 1, N Udvarhelyi 4, and B Budai 2

1 Mammographical Screening Center of the National Institute of Oncology, H-1122 Budapest, Ráth Gy u 7-9, Hungary
2 Clinical Research Department of the National Institute of Oncology, H-1122 Budapest, Ráth Gy u 7-9, Hungary
3 Department of Gynaecology of the National Institute of Oncology, H-1122 Budapest, Ráth Gy u 7-9, Hungary
4 Department of Molecular Pathology of the National Institute of Oncology, H-1122 Budapest, Ráth Gy u 7-9, Hungary

Abstract

The mammographic appearance of the female breast is influenced by physiological changes related to normal ageing (menopause), endocrine dysfunction, or the combined effects of these factors. During the period from 1 October 1995 to 30 November 1996, mammographic screening was performed on 2356 females from a Budapest district and multiple benign breast lesions (MBBL) were diagnosed in 211 (8.94%) subjects. The hormonal background of this lesion was explored by measuring serum sex hormone levels (oestradiol (E2), progesterone, testosterone, prolactin, FSH and LH) on 40 subjects randomly selected from both Group A (women with involutional changes only) and Group B (patients with MBBL). Serum E2 levels were considerably, but not statistically significantly higher in patients with MBBL (102.2±40.2 vs 50.8±18.7 pmol/l), whereas the elevations of serum progesterone (2.29±0.4 vs 0.901±0.5 nmol/l, P=0.0325) and LH (64.3±9.4 vs 48.9±13.9 IU/l, P=0.0194) levels were statistically significant.

In patients with MBBL, parallel histological studies revealed persistent lobules with cell atypia. Consequently, MBBL with distinct radiomorphological features may result from endocrine dysfunction associated with the postmenopausal period. In such cases, cell atypia is more commonly diagnosed by histology. Accordingly, MBBL can be considered as a precancerous lesion. The changes in hormone levels observed suggest that endocrine dysfunction is accompanied by a slight impairment of negative feedback regulation, and regular clinical and laboratory screening of the risk population is recommended.

Note:

Acknowledgement

This study was carried out under the auspices of the Secondary Prevention Subcomponent (1.13) of the World Bank HSM Project (3597-HU).







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the Society for Endocrinology.